BLIS represents a subset of breast cancers linked with high recurrence rates [63] and has been shown to highly express VTCN1 which encodes for B7-H4 that negatively regulates T cell activation [6, 7, 60, 68]. The gene discussed is VTCN1; the disease is breast carcinoma.